Off-Label for Pediatric Use Approved in adults: Schizophrenia (Abilify Maintena, Aristada). Maintaining stability in schizophrenia (Abilify). Bipolar
Schizophrenia: Aripiprazole (Abilify) is indicated for the treatment of schizophrenia. The efficacy of Aripiprazole (Abilify) was established in four 4-6 week
Abilify contains aripiprazole as Most of the patients with schizophrenia had the subtype of paranoid schizophrenia or undifferentiated schizophrenia.
Commonly Prescribed for Schizophrenia (adults) (Abilify, Abilify Maintena, Aristada, Aristada Initio) Schizophrenia (ages 13 to 17) (Abilify) Maintaining
Off-Label for Pediatric Use Approved in adults: Schizophrenia (Abilify Maintena, Aristada). Maintaining stability in schizophrenia (Abilify). Bipolar
For schizophrenia, the maximum daily dose of Abilify is 30 mg. For information on Abilify dosage in children with schizophrenia, see the section Children's
INDICATION OF ABILIFY 15MG TAB. 1.1 Schizophrenia: ABILIFY is indicated for the treatment of Schizophrenia. The efficacy of ABILIFY was established in four 4 –
Abilify Maintena and Abilify Asimtufii are used in adults to treat schizophrenia and bipolar disorder. Aristada is used in adults to treat schizophrenia.
Abilify Maintena and Abilify Asimtufii are used in adults to treat schizophrenia and bipolar disorder. Aristada is used in adults to treat schizophrenia.
Comments